Nanoparticle Albumin-Bound Paclitaxel With Cetuximab and Carboplatin as First-Line Therapy for Recurrent or Metastatic Head and Neck Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Oral Oncology